Drawing for Serial No. 79301302

USPTO serial 79301302

Serial No. 79301302

Reviewed by CopyMark Law Group

Reg. 6592425Status 700Registered
Filing date
Status date
Registration date
Dec 21, 2021
Examiner
MURRAY, DAVID T
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79301302?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; radiopharmaceutical diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancerACTIVE
010Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; apparatus for medical purposes, namely, drug delivery devices for diagnostic radiopharmaceuticals; medical devices for treating cancer; diagnostic imaging apparatus for medical use; radiopharmaceutical diagnostic kits consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 27, 2022FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 7, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 7, 2022FIMPFINAL DISPOSITION PROCESSED
Mar 21, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 21, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 5, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 5, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2021PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 31, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2021ALIEASSIGNED TO LIE
Aug 24, 2021NREVNOTICE OF REVIVAL - MAILED
Aug 23, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2021PETGPETITION TO REVIVE-GRANTED
Aug 23, 2021PROATEAS PETITION TO REVIVE RECEIVED
Aug 16, 2021MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 16, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 21, 2021RFNTREFUSAL PROCESSED BY IB
Feb 2, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 2, 2021RFRRREFUSAL PROCESSED BY MPU
Jan 19, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 15, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 14, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 14, 2021DOCKASSIGNED TO EXAMINER
Jan 14, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 31, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance